QA: Larimar Therapeutics Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001374690_2021_Larimar_Therapeutics_Inc.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001374690')"}

Graph

Absolute values for 0001374690, Larimar Therapeutics Inc.

  xvar xval
0 AssetsCurrent 97,952,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,040,000
3 remainder_Assets 5,694,000
4 LiabilitiesCurrent 8,992,000
5 LiabilitiesNoncurrent 6,002,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,397,000
9 ResearchAndDevelopmentExpense 31,407,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 322,000
13 remainder_ComprehensiveNetIncome 2,000
  yvar yval
0 Assets 104,686,000
1 Liabilities 14,994,000
2 Expenses 42,804,000
3 Revenues 0
4 StockholdersEquity 89,692,000
5 NetIncome -42,482,000
6 ComprehensiveNetIncome -42,481,000
7 BaseVar 81,404,000
8 EconomicCapitalRatio 1.87

Edgar->Model Mapping

Feature Distribution

Change over Time